サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768228

心臓安全サービスの世界市場

Cardiac Safety Services

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
心臓安全サービスの世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓安全サービスの世界市場は2030年までに16億米ドルに達する見込み

2024年に8億8,590万米ドルと推定される心臓安全サービスの世界市場は、分析期間2024-2030年にCAGR 10.0％で成長し、2030年には16億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるECG/ホルター測定は、CAGR 10.0％を記録し、分析期間終了時には4億7,550万米ドルに達すると予測されます。血圧測定セグメントの成長率は、分析期間でCAGR 10.8％と推定されます。

米国市場は2億2,840万米ドルと推定、中国はCAGR13.4％で成長予測

米国の心臓安全サービス市場は、2024年に2億2,840万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR13.4%で推移し、2030年までに3億6,180万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.3%と7.9%と予測されています。欧州では、ドイツがCAGR約7.4%で成長すると予測されています。

世界の心臓安全サービス市場- 主要動向と促進要因のまとめ

なぜ臨床試験で心臓安全サービスが重要なのか？

心臓安全サービスは、特に新薬を含む臨床試験において、試験中の薬が心臓に悪影響を及ぼさないことを確認するために不可欠です。これらのサービスは、不整脈、QT延長、その他薬物療法から生じる可能性のある心血管系の副作用など、潜在的な心臓リスクを監視・評価するものです。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）のような規制機関が臨床試験中の心臓安全性評価に厳しいガイドラインを設けているため、企業は新薬が患者にとって安全であることを保証するために包括的な心臓安全性プロトコルを遵守しなければならないです。

心臓安全サービスには、心電図（ECG）、ホルターモニタリング、血圧モニタリング、心エコーなどのさまざまな診断評価が含まれます。これらの評価は、心毒性の兆候を早期に発見し、医薬品開発の継続、変更、中止の判断に役立ちます。医薬品開発プロセスにおいて、患者の安全性と長期的な心血管系の健康アウトカムがますます重視されるようになるにつれて、心臓安全サービスは、治療薬が短期的な使用だけでなく、高齢者や心臓に持病のある人など、脆弱な集団における慢性的な投与においても安全であることを保証するために不可欠なものとなってきています。

技術の進歩は心臓安全サービス市場をどのように形成しているか？

技術の進歩は、臨床試験における心臓安全サービスの精度、効率、能力を大幅に向上させています。最も注目すべき進歩の1つは、継続的な心臓モニタリングのためのデジタル技術とウェアラブルの使用です。ポータブルECGモニターやウェアラブル心臓モニターなどのデバイスは、長期間にわたって心臓の活動をリアルタイムで追跡することを可能にし、治験中の患者の心臓の健康状態をより包括的に把握することができます。これらの技術は、高解像度のデータを提供するだけでなく、遠隔モニタリングも可能にするため、より柔軟な試験デザインを可能にし、患者が頻繁に臨床施設を訪れる必要性を低減します。

さらに、人工知能（AI）と機械学習（ML）の進歩は、心臓安全性データの分析方法に革命をもたらしています。AI主導のプラットフォームは、大量の心臓データを迅速に処理し、人間の分析者にはすぐにはわからないような微妙なパターンや異常を特定することができます。これらの技術はまた、心臓評価の予測能力を向上させ、潜在的リスクの早期発見を可能にし、医薬品開発プロセス全体の意思決定を強化しています。さらに、クラウドベースのソリューションは、臨床試験実施施設とスポンサー間で心臓安全性データを安全に共有することを容易にし、共同作業を改善し、規制当局への申請プロセスを迅速化しています。このような技術革新により、心臓安全サービスの信頼性とアクセシビリティが向上し、製薬企業の臨床試験の効率化に貢献しています。

どのような業界動向が心臓安全サービスの需要を牽引していますか？

心臓安全サービスの需要増加の原動力となっている業界動向はいくつかありますが、特に臨床試験の複雑化と、規制環境における心血管系の安全性重視の高まりが挙げられます。製薬会社ががん、自己免疫疾患、代謝異常などの疾患を対象としたより洗練された治療法を開発するにつれ、これらの薬剤の多くは心血管系の副作用の可能性が高くなります。これは特に生物学的製剤、免疫療法、遺伝子療法に当てはまり、患者の安全性を確保するためには心臓のモニタリングが不可欠となります。このような治療に伴う高いリスクと厳しい規制当局の監視が相まって、企業は臨床プログラムのリスクを軽減するために包括的な心臓安全サービスに多額の投資を行うようになっています。

もう一つの重要な傾向は、精密医療と患者中心の臨床試験への注目の高まりです。医薬品開発者が特定の遺伝子プロファイルや亜集団に合わせて治療法を調整するにつれ、個別化治療に伴う心臓安全性リスクは大きく変化する可能性があります。このため、より的を絞った心臓モニタリングと安全性評価が必要となります。さらに、高齢化社会における慢性疾患、特に心血管系疾患の罹患率の増加は、既往症を持つ患者が薬剤試験に参加することが多いことから、臨床試験におけるより広範な心臓安全性評価の需要を促進しています。また、患者が自宅から参加できる分散型臨床試験やハイブリッド型臨床試験の増加も、高度な遠隔心臓モニタリング・ソリューションの必要性を高めています。

心臓安全サービス市場の成長は複数の要因別もたらされる

心臓安全サービス市場の成長は、臨床試験の複雑化、モニタリング技術の進歩、心血管安全性評価に対する規制要件の増加など、いくつかの要因によってもたらされます。製薬業界がより標的を絞ったリスクの高い治療法を開発するにつれて、心臓安全性モニタリングは患者の安全性を確保するために医薬品開発プロセスに不可欠な要素となっています。臨床試験集団における心血管疾患やその他の慢性疾患の罹患率の上昇は、厳格な心臓安全性プロトコルの必要性をさらに強調しています。

AIを活用した分析、ウェアラブルECGデバイス、クラウドベースのプラットフォームなどの技術的進歩も、心臓安全性評価の精度、アクセス性、効率を向上させることで市場の成長を後押ししています。これらの技術革新は、従来の臨床試験実施施設以外の場所で参加する患者からリアルタイムの心臓データを収集するための遠隔モニタリング技術に依存する分散型臨床試験において特に重要です。さらに、個別化医療への注目の高まりは、専門的なモニタリングとデータ解析を必要とする特定の患者サブグループに合わせたカスタマイズされた心臓安全性ソリューションの需要を促進しています。

市場成長のもう一つの重要な促進要因は、特に新興市場における世界臨床試験の拡大です。製薬会社は臨床研究活動を新たな地域にも広げるため、高い精度と一貫性を維持しながら地域の規制基準に準拠したローカライズされた心臓安全サービスを必要としています。この動向は、世界中の保健当局が医薬品承認プロセスにおいてより厳格な心血管安全性データを要求するようになり、規制要件が複雑化していることも後押ししています。これらの要因と先端技術の採用拡大が相まって、心臓安全サービス市場の持続的な成長が見込まれています。

セグメント

サービスタイプ（ECG/ホルター測定、血圧測定、心血管イメージング、徹底したQT調査、その他のサービスタイプ）;エンドユーザー（製薬・バイオファーマ企業、調査受託機関）

調査対象企業の例

  • Banook Group
  • Bioclinica（A Subsidiary of Cinven）
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, L.P.
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS S.A.
  • Shanghai Medicilon Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21437

Global Cardiac Safety Services Market to Reach US$1.6 Billion by 2030

The global market for Cardiac Safety Services estimated at US$885.9 Million in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. ECG / Holter Measurement, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$475.5 Million by the end of the analysis period. Growth in the Blood Pressure Measurement segment is estimated at 10.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$228.4 Million While China is Forecast to Grow at 13.4% CAGR

The Cardiac Safety Services market in the U.S. is estimated at US$228.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$361.8 Million by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global Cardiac Safety Services Market - Key Trends & Drivers Summarized

Why Are Cardiac Safety Services Critical in Clinical Trials?

Cardiac safety services are essential in clinical trials, particularly those involving new pharmaceuticals, as they ensure that the drugs being tested do not have adverse effects on the heart. These services monitor and assess potential cardiac risks such as arrhythmias, QT prolongation, and other cardiovascular side effects that could arise from drug therapies. With regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) placing stringent guidelines on cardiac safety assessments during clinical trials, companies must comply with comprehensive cardiac safety protocols to ensure that new drugs are safe for patients.

Cardiac safety services include a range of diagnostic evaluations such as electrocardiograms (ECGs), Holter monitoring, blood pressure monitoring, and echocardiography. These assessments help detect early signs of cardiotoxicity and guide decisions on the continuation, modification, or cessation of a drug’s development. As drug development processes become increasingly focused on patient safety and long-term cardiovascular health outcomes, cardiac safety services are becoming indispensable in ensuring that therapies are safe not only for short-term use but also for chronic administration in vulnerable populations, including the elderly and those with pre-existing heart conditions.

How Are Technological Advancements Shaping the Cardiac Safety Services Market?

Technological advancements are significantly enhancing the accuracy, efficiency, and capabilities of cardiac safety services in clinical trials. One of the most notable advancements is the use of digital technologies and wearables for continuous cardiac monitoring. Devices like portable ECG monitors and wearable heart monitors allow for real-time tracking of cardiac activity over extended periods, offering a more comprehensive view of a patient’s heart health during drug trials. These technologies not only provide high-resolution data but also allow for remote monitoring, enabling more flexible trial designs and reducing the need for patients to visit clinical sites frequently.

Moreover, advancements in artificial intelligence (AI) and machine learning (ML) are revolutionizing the way cardiac safety data is analyzed. AI-driven platforms can rapidly process large volumes of cardiac data, identifying subtle patterns and abnormalities that may not be immediately apparent to human analysts. These technologies are also improving the predictive capabilities of cardiac assessments, enabling earlier detection of potential risks and enhancing decision-making throughout the drug development process. Additionally, cloud-based solutions are facilitating the secure sharing of cardiac safety data between trial sites and sponsors, improving collaboration and speeding up the regulatory submission process. These innovations are increasing the reliability and accessibility of cardiac safety services, helping pharmaceutical companies streamline their clinical trials.

What Industry Trends Are Driving the Demand for Cardiac Safety Services?

Several industry trends are driving the rising demand for cardiac safety services, particularly the increasing complexity of clinical trials and the regulatory environment’s growing emphasis on cardiovascular safety. As pharmaceutical companies develop more sophisticated therapies targeting conditions like cancer, autoimmune diseases, and metabolic disorders, many of these drugs come with a higher potential for cardiovascular side effects. This is especially true for biologics, immunotherapies, and gene therapies, where cardiac monitoring becomes critical in ensuring patient safety. The high stakes associated with these therapies, combined with stringent regulatory oversight, are pushing companies to invest heavily in comprehensive cardiac safety services to de-risk their clinical programs.

Another important trend is the growing focus on precision medicine and patient-centric trials. As drug developers tailor therapies to specific genetic profiles and subpopulations, the cardiac safety risks associated with personalized treatments can vary significantly. This necessitates more targeted cardiac monitoring and safety assessments. Additionally, the increasing incidence of chronic diseases, particularly cardiovascular diseases, among aging populations is driving demand for more extensive cardiac safety evaluations in clinical trials, as patients with pre-existing conditions often participate in drug studies. The rise of decentralized and hybrid clinical trials, in which patients can participate from home, is also boosting the need for advanced remote cardiac monitoring solutions.

Growth in the Cardiac Safety Services Market Is Driven by Several Factors

Growth in the cardiac safety services market is driven by several factors, including the rising complexity of clinical trials, advancements in monitoring technologies, and increasing regulatory requirements for cardiovascular safety assessments. As the pharmaceutical industry develops more targeted and high-risk therapies, cardiac safety monitoring has become an integral part of the drug development process to ensure patient safety. The rising incidence of cardiovascular diseases and other chronic conditions in clinical trial populations further emphasizes the need for stringent cardiac safety protocols.

Technological advancements, such as AI-powered analytics, wearable ECG devices, and cloud-based platforms, are also propelling market growth by improving the accuracy, accessibility, and efficiency of cardiac safety assessments. These innovations are particularly important in decentralized clinical trials, which rely on remote monitoring technologies to collect real-time cardiac data from patients participating outside of traditional trial sites. Moreover, the increasing focus on personalized medicine is driving demand for customized cardiac safety solutions tailored to specific patient subgroups, requiring specialized monitoring and data analysis.

Another key driver of market growth is the expansion of global clinical trials, particularly in emerging markets. As pharmaceutical companies broaden their clinical research activities to new regions, they require localized cardiac safety services that comply with regional regulatory standards while maintaining high levels of precision and consistency. This trend is further supported by the increasing complexity of regulatory requirements, as health authorities worldwide demand more rigorous cardiovascular safety data during the drug approval process. These factors, combined with the growing adoption of advanced technologies, are expected to drive the sustained growth of the cardiac safety services market.

SCOPE OF STUDY:

The report analyzes the Cardiac Safety Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, Other Service Types); End-Use (Pharma & Biopharma Companies, Contract Research Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Banook Group
  • Bioclinica (A Subsidiary of Cinven)
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, L.P.
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS S.A.
  • Shanghai Medicilon Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Cardiac Safety Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Drug-Induced Cardiotoxicity Drives Demand for Cardiac Safety Assessment Services
    • Increasing Emphasis on Patient Safety and Regulatory Compliance Strengthens Market Demand for Cardiac Safety Monitoring in Clinical Trials
    • Growth in Drug Development and Clinical Research Activities Expands Addressable Market for Cardiac Safety Services
    • Technological Advancements in Cardiac Imaging and Biomarkers Propel Adoption of Advanced Cardiac Safety Assessment Methods
    • Rising Demand for Comprehensive ECG and QT Interval Monitoring in Clinical Trials Boosts Cardiac Safety Service Market
    • Growing Focus on Early Detection of Cardiotoxicity in Oncology and Immunotherapy Creates New Growth Opportunities in Cardiac Safety Services
    • Expansion of Contract Research Organizations (CROs) and Outsourcing of Cardiac Safety to Specialized Providers Fuels Market Growth
    • Increasing Use of Wearable and Remote Monitoring Devices in Clinical Trials Enhances Real-Time Cardiac Safety Data Collection
    • Growing Integration of AI and Machine Learning in Cardiac Safety Analytics Improves Predictive Capabilities and Efficiency
    • Rising Adoption of Electrocardiographic Monitoring in Early-Phase Clinical Trials Strengthens Market for Cardiac Safety Services
    • Increasing Demand for Non-Invasive Cardiac Monitoring Methods Expands Scope of Cardiac Safety Services in Diverse Patient Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Cardiac Safety Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for ECG / Holter Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Blood Pressure Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiovascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Thorough QT Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • INDIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION